New app-based program aims to fix night-shift workers' sleep and weight
NCT ID NCT07631767
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This European trial tests a 24-week lifestyle program for 400 night-shift workers. The program, delivered via a mobile app and workshops, focuses on sleep, stress, diet, and exercise. The goal is to see if it helps workers sleep longer and improve their health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Combined Lifestyle Intervention (behavioral program via mobile app and workshops)
What this could lead to
If successful, this could offer a practical way for night-shift workers to improve sleep and reduce obesity risk.
What could go wrong
This is a behavioral intervention, not a drug, so effects may be modest. The trial is not yet recruiting and results may not apply to all shift workers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus Medical Centre
Rotterdam, Netherlands
-
Lodz
Lodz, Poland
-
TTZ
Bremerhaven, Germany
-
Uni Bremen
Bremen, Germany
-
Wageningen University & Research
Wageningen, Netherlands